Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on Capital EmployedReturn on Invested CapitalTimes Interest Earned

Lifecore Biomedical, Inc. \De\ (LFCR) Return on Equity (2016 - 2025)

Lifecore Biomedical, Inc. \De\ (LFCR) has 15 years of Return on Equity data on record, last reported at 0.0% in Q1 2025.

  • For Q1 2025, Return on Equity fell 4.0% year-over-year to 0.0%; the TTM value through Feb 2025 reached 0.0%, down 4.0%, while the annual FY2024 figure was 0.76%, 160.0% up from the prior year.
  • Return on Equity reached 0.0% in Q1 2025 per LFCR's latest filing, down from 0.14% in the prior quarter.
  • Across five years, Return on Equity topped out at 4.22% in Q4 2023 and bottomed at 2.29% in Q2 2023.
  • Average Return on Equity over 5 years is 0.24%, with a median of 0.06% recorded in 2022.
  • Peak YoY movement for Return on Equity: skyrocketed 449bps in 2023, then crashed -408bps in 2024.
  • A 5-year view of Return on Equity shows it stood at 0.02% in 2021, then tumbled by -1033bps to 0.26% in 2022, then soared by 1709bps to 4.22% in 2023, then crashed by -97bps to 0.14% in 2024, then crashed by -101bps to 0.0% in 2025.
  • Per Business Quant database, its latest 3 readings for Return on Equity were 0.0% in Q1 2025, 0.14% in Q4 2024, and 0.22% in Q3 2024.